MiWeigh Program for Obesity

This trial tests a program called MiWeigh to determine if it aids in weight loss more effectively than receiving weight loss advice alone. Researchers aim to identify which components of MiWeigh are effective and how it might help prevent or manage obesity-related issues such as Type 2 Diabetes or high blood pressure. Individuals with a BMI of 30 or higher, along with conditions like Type 2 Diabetes, prediabetes, or high cholesterol, who are interested in losing weight, may be suitable candidates. Participants must be comfortable using electronic health tools and report their weight weekly if assigned to the program. As an unphased trial, this study provides a unique opportunity to contribute to innovative weight management strategies that could benefit many people.

The trial does not specify if you need to stop taking your current medications. However, if you are taking an anti-obesity medication, you cannot participate in the trial.

Research shows that most people find the MiWeigh program easy to manage. A study on a similar weight loss program produced good results without major side effects, suggesting participants experienced no significant issues.

Unlike other treatments for obesity that often involve medications or surgical interventions, the MiWeigh program focuses on a comprehensive lifestyle approach. Researchers are excited about MiWeigh because it integrates personalized coaching, technology-driven tracking, and community support to help individuals make sustainable lifestyle changes. This holistic approach not only aims to reduce weight but also to improve overall health and well-being, making it a potentially transformative option for individuals struggling with obesity.

Research has shown that the MiWeigh program, which participants in this trial may receive, can aid in weight loss. One study found that people in the MiWeigh program lost significant weight, with some losing more than 10% of their body weight after a year. Another study reported an average weight loss of 15.3% in just four months. This trial will compare the MiWeigh program to Enhanced Usual Care, which provides information about weight loss. The program's structured plan appears crucial for these outcomes.¹²⁶⁷⁸